Uruguay Surrogacy: Medical and Donor Requirements
In Uruguay, the key question is not simply whether a clinic offers IVF or donor gametes. Surrogacy is governed by a narrow statutory exception, with specific medical, family-relationship, embryo and agreement conditions. Separate rules govern assisted reproduction generally and gamete donation. A clinic may apply additional clinical criteria, but its policy cannot expand the legal exception. This guide checks the official consolidated legal texts available on 23 October 2026; administrative practice and clinic-specific protocols still require written confirmation.
Quick decision matrix
Start with a documented genetic or acquired disease that prevents the intended woman from gestating. The treating team must report the incapacity to the Honorary Commission; kinship, embryo genetics, the gratuitous agreement, donor requirements and provider authorisation must also meet the statutory rules.
| Issue | Binding rule identified | What to verify before treatment |
|---|---|---|
| Medical threshold | The intended woman’s uterus cannot gestate because of a genetic or acquired disease. | A treating-team diagnosis and report to the Honorary Commission; confirm the Commission’s current review process. |
| Age and funding | The statute sets a general age rule of adulthood to under 60; Decree 84/015 art. 7 also includes a new-IVF-cycle cutoff at 40 and a time-limited route for ages 40 to under 60. | Get current written advice on treatment eligibility and a separate FNR funding decision; check donor-specific rules separately. |
| Gestational carrier | A second-degree blood relative of the intended woman or, where applicable, her partner. | Civil records or other reliable proof of the relationship and written confirmation that the degree qualifies. |
| Embryo genetics | At least one gamete must come from the couple; for a single woman, the egg must be hers. | A written gamete-source plan. Donor sperm may be compatible in a couple if the other gamete is from a member of the couple; a single woman must use her own egg. |
| Agreement | The permitted agreement must be gratuitous, written and signed by every participant. | A final agreement and a clear explanation of any proposed reimbursements or expenses; do not assume a paid arrangement is allowed. |
| Gamete donors | Donors must be adults and meet health-screening requirements; donation is anonymous and altruistic, subject to a judicial identity-disclosure route. | Written informed consent, screening records, donor-use limits and the clinic’s record-traceability process. |
| Clinic and treatment | ART must be provided by a specifically authorised institution; general safety, records and consent rules also apply. | The institution’s current Ministry of Public Health authorisation and the written clinical protocol for each participant. |
1. The surrogacy exception is narrow
Law 19.167 art. 25 declares absolutely null paid or unpaid agreements under which a woman carries a pregnancy with gametes or embryos supplied by a couple or woman and must hand the child to them or a third party, unless the narrow statutory exception applies. That exception is not general permission for altruistic surrogacy.
The exception requires a woman whose uterus cannot carry the pregnancy because of a genetic or acquired disease. The carrier must be a second-degree blood relative of that woman or, where applicable, of her partner. The law does not describe a friend, unrelated volunteer or merely willing carrier as an alternative. Because kinship wording can be applied to particular family trees, obtain written confirmation of the exact relationship from the treating team and Uruguayan counsel or the competent Commission before any treatment.
The agreement must be gratuitous, recorded in writing and signed by all participants. This is a statutory condition, not simply a preferred clinic form. Do not treat a label such as ‘expenses’, ‘compensation’ or ‘service fee’ as legally decisive: ask local counsel to classify each proposed payment against the no-remuneration requirement before money changes hands.
2. Medical proof and general ART safeguards
The relevant diagnosis is not merely infertility, a low predicted IVF success rate or a personal preference not to carry a pregnancy. The statutory wording concerns inability of the uterus to gestate due to a genetic or acquired disease. The treating medical team must diagnose that incapacity and submit a report to the Honorary Commission on Assisted Human Reproduction; the Commission evaluates whether the conditions in the surrogacy exception are satisfied. Keep the signed diagnosis, supporting investigations and proof that the report was submitted. Submission should not be described as approval unless the competent body has actually confirmed the outcome.
General ART rules require reasonable prospects of success and no grave risk to the woman or possible offspring. A mandatory protocol must assess psychophysical health and screen for genetic, hereditary or infectious diseases that compromise embryo viability or can be transmitted to descendants and cannot be treated after birth. For high-complexity procedures, the doctor must record supporting studies, treatments and results in the medical file. Written informed consent and treatment-stage written ratification are required. Ask the clinic to identify the forms for intended parent(s) and carrier separately.
Law 19.167 art. 7 sets a general ART age rule of adulthood to under 60, subject to its exception for a person declared incapable of exercising parenthood. Yet Decree 84/015 art. 7(a) says new IVF cycles may not begin after a woman turns 40; three transfer cycles may continue after 40 if embryos were already cryopreserved. Its art. 7(b), amended by Decree 46/017, set a separate route for ages 40 to under 60 during a 24-month transition window; that window has expired, though FNR coverage may remain for applicants who filed complete documents within it. Decree 429/022 added an oncology gamete-preservation rule, not a general age amendment. The texts do not clearly resolve current clinical eligibility versus FNR funding. Obtain written current advice for the intended parent(s) and carrier, plus a separate funding decision. Donors have a separate adult-status and screening rule (Decree 84/015 art. 14); do not automatically apply the patient age rule to them. Clinic advertising does not establish a nationwide carrier-specific age, BMI or prior-pregnancy threshold.
3. The embryo must meet the statutory definition
The embryo used in the permitted surrogacy arrangement must be an ‘own embryo’ as defined by law: it must be formed from at least one gamete of the couple or, for a single woman, from her own egg.
For a couple, the wording allows the possibility that one gamete is donated if the other comes from a member of the couple, subject to the applicable medical and regulatory requirements. For a single woman, the statutory definition specifically requires her own ovum; a donor egg would not meet that definition. An embryo formed from both donor sperm and donor egg would not meet the stated ‘own embryo’ test for this exception. Do not assume that permission to use donor gametes in ordinary ART automatically makes every donor combination available in surrogacy.
Before stimulation, fertilisation or transfer, ask the clinic to provide a written embryo-source plan identifying whose egg and sperm will be used, which gametes are donated, and how the plan satisfies the exact statutory definition. If a proposed plan depends on an interpretation not expressly addressed in the text, obtain a written position from the competent Uruguayan authority or qualified local counsel.
4. Donor eligibility, screening and clinic authorisation
Under Law 19.167, gamete donors must be adults and must demonstrate good psychophysical health under a mandatory testing protocol. The screening must establish that they do not have genetic, hereditary or infectious diseases that compromise embryo viability or are transmissible to descendants and cannot be treated after birth. Decree 84/015 repeats these donor requirements for high-complexity ART. This screening standard does not guarantee a child will have no medical condition.
The rules do not give a complete list in the statute of every laboratory assay, carrier-screening panel, test validity period or clinical cut-off that will apply in an individual case. Those details may depend on the current Ministry of Public Health protocol and the clinic’s documented medical policy. Ask for the actual screening protocol and results relevant to the proposed donation, including what was tested, what was not tested, how inconclusive findings are handled and whether further tests are recommended. Do not accept a clinic’s shorthand ‘fully screened’ without knowing its meaning.
Only institutions authorised by the Ministry of Public Health for the relevant assisted-reproduction activities may perform ART; a gamete bank also requires specific authorisation and is subject to supervision. Verify the current authorisation of the actual provider and, where relevant, its gamete bank or laboratory. A marketing page, overseas accreditation or general medical licence is not a substitute for confirming the Uruguayan authorisation required for the procedure.
5. Donor consent, limits, identity and legal status
Donation under the high-complexity rules is anonymous and altruistic, and the donor’s identity data must remain confidential subject to the statutory exception. The donation must be authorised in writing with the donor’s express informed consent. The regulation says consent may be revoked in writing when the donor needs the donated gametes for their own use. Ask the clinic to explain when revocation remains practically possible, what happens to gametes already used or embryos already created, and which records document consent; do not infer answers beyond the legal text.
Decree 84/015 sets numerical limits: sperm from one donor may result in no more than 25 births; for an egg donor, there may be up to five stimulations, no more than three in one year, and no more than 25 births. The clinic should explain how it tracks donor use across recipients and complies with national traceability and registration duties. These are regulatory limits, not success-rate estimates and not a guarantee that a donor has been used fewer times unless the records support that statement.
Recipients are entitled to general information about a donor’s phenotypic characteristics. Donor identity is not routinely disclosed, but Law 19.167 provides a judicial route for identity disclosure when the person born through ART, or eligible descendants, request it from the competent judge. The statute also says gamete donation does not create a legal parent-child relationship or reciprocal rights and duties between donor and child. These donor rules do not, by themselves, resolve the separate parentage and birth-registration questions arising from surrogacy.
6. What is law, and what may be clinic policy?
The binding rules are the statutory exception and conditions described above, donor-specific requirements, and the authorisation and safety duties imposed on ART providers.
A clinic may add safeguards such as broader genetic or infection panels, psychological assessment, prior-pregnancy limits, BMI criteria or shorter test-validity periods. Some may be required by a Ministry protocol or justified clinically; others may be internal selection rules. The surrogacy-specific provisions do not give one exhaustive, role-specific list of carrier criteria. Ask the clinic to classify each extra criterion as law, Ministry protocol, case-specific clinical judgment or internal policy, and explain the consequence of a failed or borderline result.
Do not confuse clinical acceptance with legal eligibility, and do not confuse either with funding. Decree 84/015 sets separate conditions for access to National Resources Fund coverage, including residence in Uruguay and contributions through a legally recognised system. Nor does medical clearance automatically settle legal parentage, registration, nationality or travel. Those questions require separate analysis and should not be promised as a consequence of clinic approval.
7. Documents and answers to obtain before treatment
Before treatment, request one written file containing at least:
- The treating team’s signed diagnosis of the genetic or acquired disease preventing the intended woman from gestating, with supporting records and tests.
- Proof the report was sent to the Honorary Commission, plus its current position or next step; submission alone is not approval.
- Civil records or other reliable evidence of the carrier’s relationship to the intended woman or her partner, and written confirmation that it meets second-degree consanguinity.
- A written gamete/embryo plan naming egg and sperm sources, any donor gametes, and how the embryo meets the statutory definition.
- Donor eligibility and screening records, written consent, use-limit/registry confirmation, phenotype-information terms and possible judicial identity disclosure.
- The gratuitous agreement signed by all participants; separate clinical consents; explanation of proposed expenses/reimbursements; and current Ministry authorisation for the clinic, laboratory and any gamete bank.
- Medical safety and reasonable-success assessments, applicable test protocol, treatment-stage consent/ratification requirements, a written age-rule determination and separate FNR funding decision; identify the legal/protocol basis for extra clinic criteria.
8. A safe decision path and limits of this guide
Use decision gates, not verbal assurances: document the medical basis; verify kinship; confirm gamete sources; obtain the Commission’s status, signed agreement and participant-specific consents; then verify provider authorisations, donor records and protocols. Have Uruguayan counsel and the treating specialist confirm these conditions before treatment.
If the clinic cannot cite a legal basis, produce required records, or gives conflicting answers about donor use, kinship or the Commission’s role, pause and request written clarification. Have the file reviewed by Uruguayan reproductive-law counsel and a fertility specialist. This guide reflects official consolidated Law 19.167 and Decree 84/015, including Decrees 46/017 and 429/022, as of 23 October 2026.
Primary legal sources
- Law No. 19.167 — Assisted Human Reproduction Techniques (official consolidated text) Relevant provisions: arts. 4, 7, 12–16 and 21–26.
- Decree No. 84/015 — Regulation of Law No. 19.167 (official consolidated text) Relevant provisions: arts. 4, 7, 13–17, 21–28 and 31; consolidated text.
- Decree No. 46/017 — Amendment to Decree 84/015 Relevant provision: art. 1 amended Decree 84/015 art. 7(b), including the time-limited age and FNR coverage route.
- Decree No. 429/022 — Update to the regulation of Law No. 19.167 Relevant provisions: arts. 1–4; includes the oncology-related gamete-cryopreservation amendment; checked against the consolidated framework.
